Praxis Precision Medicine Q3 EPS $(3.36) Beats $(3.43) Estimate
Author: Benzinga Newsdesk | November 05, 2025 08:04am
Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(3.36) per share which beat the analyst consensus estimate of $(3.43) by 1.96 percent. This is a 22.18 percent decrease over losses of $(2.75) per share from the same period last year.